Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC) Meeting Abstract


Authors: Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; Gajria, D.; Moynahan, M. E.; Traina, T. A.; Chen, M.; Hamilton, N.; Patil, S.; Chandarlapaty, S.; Hudis, C.; Dang, C. T.
Abstract Title: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419600111
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.606
Notes: Meeting Abstract: 606 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Mary Ellen Moynahan
    105 Moynahan
  3. Clifford Hudis
    905 Hudis
  4. Chau Dang
    271 Dang
  5. Diana E Lake
    89 Lake
  6. Maura N Dickler
    262 Dickler
  7. Farrah Mikhail Datko
    9 Datko
  8. Monica Nancy Fornier
    158 Fornier
  9. Devika Gajria
    31 Gajria
  10. Elizabeth Comen
    72 Comen
  11. Tiffany A Traina
    250 Traina
  12. Shanu Modi
    265 Modi
  13. Shari Goldfarb
    149 Goldfarb
  14. Julie Fasano
    10 Fasano
  15. Melanie Fanny Chen
    6 Chen